PMID- 38213859 OWN - NLM STAT- MEDLINE DCOM- 20240115 LR - 20240115 IS - 1555-1377 (Electronic) IS - 1541-5457 (Print) IS - 1541-5457 (Linking) VI - 43 IP - 2 DP - 2023 Dec TI - Sex Differences in Patient-Reported Outcomes Following Surgical Hip Preservation Interventions: A Systematic Review and Meta-Analysis. PG - 133-145 AB - BACKGROUND: Female patients undergoing hip preservation surgery often have inferior patient-reported outcome scores (PROs), raising concerns about the clinical benefit of hip preservation surgery in women. Comparison of preoperative and postoperative PROs, and change in PROs, for female versus (vs.) male hip preservation patients was completed via systematic review. METHODS: In accordance with PRISMA guidelines, the MEDLINE, Cochrane Central, and Em-base databases were searched. Level I-IV studies of patients undergoing surgical intervention for femoroacetabular impingement (FAI) and/or developmental dysplasia of the hip (DDH) with at least two years of postoperative follow-up were included. Sex-stratified PRO scores or outcome information had to be included. RESULTS: We identified 32 hip preservation studies evaluating sex-related PRO differences, and/or providing sex-specific PRO data. The quantitative analysis of 24 studies (1843 patients) was stratified by DDH status. The modified Harris Hip Score (mHHS), Hip Outcome Score-Activities of Daily Living subscale (HOS-ADL), and Hip Outcome Score-Sport-Specific subscale (HOS-SSS) were assessed. Patients undergoing surgery for FAI only were 52.1% female (n= 806/1546). As predicted, women had lower preoperative PRO scores, however, they had significantly greater improvements in HOS-ADL (20.14+/-4.41 vs. 26.00+/-0.35, p<0.05) and HOS-SSS (33.21+/- 0.71 vs. 38.33+/- 0.46, p<0.05) compared to males. Similar results were found in the DDH cohort of 330 patients (72.1% female): females had lower preoperative PRO scores, but significantly greater improvement of mHHS (22.68+/-0.45 vs. 10.60+/-1.46, p<0.01). CONCLUSION: The present review suggests that men undergoing surgery for FAI and/or DDH tend to have higher preoperative and postoperative PRO scores. However, it appears that women often have greater preoperative to postoperative improvement in PRO scores. This finding is strongest in surgical treatment of DDH. Level of Evidence: III. CI - Copyright (c) The Iowa Orthopaedic Journal 2023. FAU - Parker, Emily A AU - Parker EA AD - Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. FAU - Peoples, Rebecca AU - Peoples R AD - Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. FAU - Willey, Michael C AU - Willey MC AD - Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. FAU - Westermann, Robert W AU - Westermann RW AD - Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. LA - eng PT - Journal Article PT - Meta-Analysis PT - Systematic Review PL - United States TA - Iowa Orthop J JT - The Iowa orthopaedic journal JID - 8908272 SB - IM MH - Humans MH - Male MH - Female MH - *Hip Joint/surgery MH - Treatment Outcome MH - Activities of Daily Living MH - Sex Characteristics MH - Arthroscopy/methods MH - *Femoracetabular Impingement/surgery MH - Patient Reported Outcome Measures MH - Follow-Up Studies MH - Retrospective Studies PMC - PMC10777693 OTO - NOTNLM OT - clinical assessment/grading scales OT - femoroacetabular impingement syndrome OT - hip arthroscopy OT - hip labral tears OT - medical aspects of sports OT - patient-reported outcome scores OT - patient-reported outcomes OT - sex-based physiologic differences COIS- Disclosures: EAP and RP declare no competing interests. MCW reports personal fees from Dupuy Synthes Sales Inc, other from Smith and Nephew, personal fees from Zimmer Biomet Inc, personal fees from Stryker Corp, outside the submitted work. RWW reports personal fees, non-financial support, and other from Smith & Nephew, other from Arthrex, other from Wardlow Enterprises, personal fees from Medical Device Business Systems, personal fees from Linvatec Corp, outside the submitted work. EDAT- 2024/01/12 06:42 MHDA- 2024/01/15 12:43 PMCR- 2023/12/01 CRDT- 2024/01/12 03:48 PHST- 2024/01/15 12:43 [medline] PHST- 2024/01/12 06:42 [pubmed] PHST- 2024/01/12 03:48 [entrez] PHST- 2023/12/01 00:00 [pmc-release] PST - ppublish SO - Iowa Orthop J. 2023 Dec;43(2):133-145.